A new beta receptor blocking agent LB-46 in angina pectoris. (A double blind clinical trial)
Srivastava, B.N.; Jain, P.C.; Vyas, G.P.
Indian Heart Journal 24(Suppl 1): 203-204
1972
ISSN/ISBN: 0019-4832 PMID: 4581428 Document Number: 48654
Document emailed within 1 workday
Related Documents
Erikssen, J.; Rod, T. 1971: Treatment of angina pectoris with cardioselective beta blocking agents. Double blind study with Eraldin (practolol) Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 91(10): 721-725Dhawan, S.; Soni, D.; Chandra, N.; Dviwedi, S.; Agarwal, A.; Puri, V.K. 1992: Use of captopril as an isolated agent for the management of stable angina pectoris--a double blind randomised trial Indian Heart Journal 44(3): 151-154
Sagar, S.; Pandhi, P.; Anand, I.S.; Sharma, P.L.; Wahi, P.L. 1985: Double-blind crossover clinical trial of oxyfedrine and propranolol in angina pectoris International Journal of Clinical Pharmacology Therapy and Toxicology 23(4): 186-189
Greif, S.; Roth, F.; Harnoncourt, K. 1977: The treatment of angina pectoris with a fixed combination of a beta-adrenoceptor blocker and a long-acting nitrate (double-blind trial) Schweizerische Rundschau für Medizin Praxis 66(48): 1554-1559
Forrest, W.A. 1975: A double-blind clinical trial in angina pectoris. a comparison between oxprenolol, practolol and placebo British Journal of Clinical Practice 29(12): 343-346
Ilyas, M.; Jafary, M.H.; Peracha, M.A.; Janjua, M.; Khan, N. 1975: Double blind trial of propranolol and pindolol in angina pectoris Jpma. Journal of the Pakistan Medical Association 25(7): 165-166
De Ponti, C.; Mauri, F.; Fiorista, F.; Ciliberto, G.R.; Carù, B.; Rovelli, F. 1977: Effectiveness of nifedipine on exercise tolerance in patients with angina pectoris. Comparison with a nitroderivative and a beta-blocking agent Giornale Italiano di Cardiologia 7(12): 1162-1171
Morledge, J. 1973: Effects of perhexiline maleate in angina pectoris: a double-blind clinical evaluation with ECG-treadmill exercise testing Postgraduate Medical Journal 49(Suppl 3): 64-67
Mantykow, J.E.; Lepera, L.; Slafer, H.; Conti, L.; Lo Russo, J. 1970: Double-blind test of C.39'089-Ba in angina pectoris Prensa Medica Argentina 57(24): 1209-1212
Cunha, G.P.; Lopes, M.; Maranhão, M.F.; Oliveira, P.F.; Rojas, R.I. 1975: Perhexiline maleate in the treatment of angina pectoris - double blind study Arquivos Brasileiros de Cardiologia 28(3): 379
De Vita, C.; Cadel, A.; Carú, B.; Mazzini, C.; Parenti, G.F. 1973: Use of beta-adrenolytic agent in the treatment of angina pectoris Minerva Cardioangiologica 21(4): 304-316
Lehmann, H.; Hochrein, H. 1976: Efficacy of lidoflazine in angina pectoris. a long-term double-blind study Medizinische Klinik 71(5): 189-196
Boye, E. 1975: Crossed double-blind multicentric studies of the effect of verapamil in patients with angina pectoris Minerva Medica 66(39): 1883-1886
Weng, W.L.; Zhang, W.Q.; Liu, F.Z.; Yu, X.C.; Zhang, P.W.; Liu, Y.N.; Chi, H.C.; Yin, G.X.; Huang, M.B. 1984: Therapeutic effect of Crataegus pinnatifida on 46 cases of angina pectoris--a double blind study Journal of Traditional Chinese Medicine 4(4): 293-294
Stroobandt, R.; Kesteloot, H. 1984: Dose related efficacy of betaxolol in combination with nitroglycerin in patients with angina pectoris: a double blind cross-over study Archives Internationales de Pharmacodynamie et de Therapie 267(2): 299-309
Eteiba, H.; Hutton, I.; Foale, R.A.; Akhras, F.; Jackson, G.; Prescott, R.J.; Hallam, R.J.; Quinn, K.J. 1991: Acute and chronic effects of once-daily isosorbide-5-mononitrate on the exercise capacity of patients with angina pectoris treated with a beta-blocking drug British Journal of Clinical Practice 45(3): 185-188
Eriksen, C.A.; Cheadle, W.G.; Cranford, C.A.; Cuschieri, A. 1988: Combined cimetidine-alginate antacid therapy versus single agent treatment for reflux oesophagitis: results of prospective double-blind randomised clinical trial Annales Chirurgiae et Gynaecologiae 77(4): 133-137
Bergmann, K.; Horák, O. 1970: Trimepranol, a new Czechoslovak sympatholytic beta receptor blockader. I. in angina pectoris therapy Casopis Lekaru Ceskych 109(22): 473-476
Ionescu, M.A.; Baroni, A.; Brambilla, L.; Cannavò, S.P.; Cristaudo, A.; Vedove, C.Dalle.; Frasca, M.; Girolomoni, G.; Gnecchi, L.; Peris, K.; Trifirò, C.; Matta, A.M.; Robert, G. 2011: Double blind clinical trial in a series of 115 patients with seborrheic dermatitis: prevention of relapses using a topical modulator of Toll like receptor 2 Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 146(3): 185-189
Pruksananonda, K.; Suwajanakorn, S.; Sereepapong, W.; Virutamasen, P. 2004: Comparison of two different fixed doses of follitropin-beta in controlled ovarian hyperstimulation: A prospective randomized, double blind clinical trial Journal of the Medical Association of Thailand 87(10): 1151-1155